2-(Pyridin-4-yl)aniline

Catalog No.: 
ACXZTL413
CAS No.: 
106047-18-1
Molecular Formula: 
C11H10N2
Molecular Weight: 
170.21
2-(Pyridin-4-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$73.00In stockIn stock
1g95%$132.00In stockIn stock
5g95%$650.00InquiryInquiry
25g95%$2763.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-4-yl)aniline
IUPAC Name2-(pyridin-4-yl)aniline
MDL No.MFCD06738704
Molecular FormulaC11H10N2
Molecular Weight170.21
SMILESNC1=CC=CC=C1C2=CC=NC=C2
InChI KeyODRIUFNOBKDEJX-UHFFFAOYSA-N
Synonym2-PYRIDIN-4-YL-PHENYLAMINE;Benzenamine,2-(4-pyridinyl)-;2-(pyridin-4-yl)aniline;2-(4-Pyridinyl)benzenamine
CAS No.106047-18-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXZTL413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXZTL413 route product structure diagram
    ACXZTL413106047-18-1In Stock
Inquiry

2. ACXZTL413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGWL165 route compound structure diagram
    ACCGWL16594718-79-3In Stock
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACXZTL413 route product structure diagram
    ACXZTL413106047-18-1In Stock
Inquiry

3. ACXZTL413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXZTL413 route product structure diagram
    ACXZTL413106047-18-1In Stock
Inquiry

Comments (0)